Neoadjuvant chemotherapy and targeted therapy in breast cancer: past, present, and future.

J Oncol · 2013 · PMC3762209 · PMID 24027583

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

Again, pCR was a highly significant surrogate marker for better outcome [ 1 ].

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.